Digital Look

Novartis Ag Ads (NVS)

$ 51.96

Date: Tuesday 25 Oct 2011

Novartis the Swiss pharaceuticals company, is to lay off 2000 employees as part of a $200m cost saving plan.

No recent information was found.

Pfizer Acquires Rights to Treatment for Rare Dis...	02-Dec-2009	New York Times
Tech Ticker	10-Oct-2009	BayArea.com
Amgen Cites Benefits of Osteoporosis Drug	08-Jul-2009	New York Times
HGS Reports Early Positive Results for Hepatitis...	09-Dec-2008	Washington Post
Amgen osteoporosis drug denosumab cuts fracture ...	17-Sep-2008	LA Times

Some companies (like Wal-Mart) thrive despite re...	04-Dec-2008	USA Today
Biotech Campaigns for Easier Access to Generic D...	13-Aug-2008	Washington Post
Stocks pull back gains, end trading day mixed	08-Apr-2008	Wall Street Journal
Stocks mixed as investors look ahead to earnings...	08-Apr-2008	USA Today
Dow Opens With Big Gain But Pulls Back Ahead of ...	08-Apr-2008	Washington Post

FDA Approves New Lotrel(R) 5/40 mg and 10/40 mg ...	09-Jun-2006	Market Wire
Diovan(R) (Valsartan) the First Blood Pressure M...	19-May-2006	Market Wire
Repeat - Novartis Announces Efficacy Data on New...	17-May-2006	Market Wire
Novartis Announces Efficacy Data on New Investig...	17-May-2006	Market Wire
FDA Approves Higher Dose Formulations of Diovan ...	01-May-2006	Market Wire

Novartis Pharmaceuticals Corporation Prevails in...	16-Oct-2009	PR Newswire
Peptimmune Completes Phase Ib Study of PI-2301 i...	25-Aug-2009	PR Newswire
Gen-Probe Reports Strong Financial Results for F...	17-Feb-2009	PR Newswire
Gen-Probe and Novartis Agree to Extend and Expan...	27-Jan-2009	PR Newswire
Peptimmune Grants Major Pharmaceutical Company E...	15-Jan-2009	PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.